Discover

CRC
California Resources Corporation
52.96
100 x 53.20
300 x 53.28
bid
ask
-
0.09
0.17%
200 @ 05:34 PM
52.96 +0.00 (0.00%)
Ytd18.45%
1y2.00%
48.74
day range
53.49
43.55
52 week range
70.13
Open52.72Prev Close53.05Low48.74High53.49Mkt Cap4.70B
Vol686.88KAvg Vol833.21KEPS-1.29P/EN/AForward P/E13.75
Beta1.02Short Ratio4.25Inst. Own105.72%Dividend1.62Div Yield3.05
Ex Div Date09-04Earning11-0250-d Avg53.21200-d Avg56.411yr Est76.50

CRC News

California Resources Corporation Schedules Third Quarter 2026 Earnings Conference Call
globenewswire.com
California Resources Corporation Schedules Third Quarter 2026 Earnings Conference Call

LONG BEACH, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) p

AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
gurufocus.com
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closing of AstraZeneca's (LSE

Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
gurufocus.com
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Ev

Summit Therapeutics Inc. (Nasdaq: SMMT) today announced a clinical trial collaboration agreement wit

Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
prnewswire.com
Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer scree

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and b

Head to Head Comparison: California Resources (NYSE:CRC) versus Kinetik (NYSE:KNTK)
defenseworld.net
Head to Head Comparison: California Resources (NYSE:CRC) versus Kinetik (NYSE:KNTK)

California Resources (NYSE: CRC - Get Free Report) and Kinetik (NYSE: KNTK - Get Free Report) are bo

Freenome: SimpleScreen CRC Unlocks A 50M Patient TAM, Bypassing Competition
seekingalpha.com
Freenome: SimpleScreen CRC Unlocks A 50M Patient TAM, Bypassing Competition

Freenome is rated Buy, leveraging FDA-approved SimpleScreen CRC and a $410M cash reserve to target t

California Resources to Divest Uinta Basin Assets for $90 Million
zacks.com
California Resources to Divest Uinta Basin Assets for $90 Million

CRC plans to sell its non-core Uinta Basin assets for about $90 million, freeing cash to support its

benzinga.com
Stephens & Co. Maintains Overweight on California Resources, Lowers Price Target to $91

Stephens & Co. analyst Mike Scialla maintains California Resources (NYSE:CRC) with a Overweig

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
gurufocus.com
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedot

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the Europea

benzinga.com
Roth Capital Maintains Buy on California Resources, Raises Price Target to $59

Roth Capital analyst Leo Mariani maintains California Resources (NYSE:CRC) with a Buy and raises

California Resources Corporation Announces Divestiture of Uinta Basin Assets
globenewswire.com
California Resources Corporation Announces Divestiture of Uinta Basin Assets

LONG BEACH, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC)

benzinga.com
RBC Capital Reiterates Outperform on California Resources, Maintains $77 Price Target

RBC Capital analyst Scott Hanold reiterates California Resources (NYSE:CRC) with a Outperform and

Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu
gurufocus.com
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Com

Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/ur

Why Is California Resources (CRC) Up 2.7% Since Last Earnings Report?
zacks.com
Why Is California Resources (CRC) Up 2.7% Since Last Earnings Report?

California Resources (CRC) reported earnings 30 days ago. What's next for the stock?

California Resources Completes $63M Acquisition of Crimson Midstream
zacks.com
California Resources Completes $63M Acquisition of Crimson Midstream

CRC's $63 million Crimson acquisition expands its California pipeline network, boosting transport fl

California Resources Corporation Completes Acquisition of Crimson
globenewswire.com
California Resources Corporation Completes Acquisition of Crimson

LONG BEACH, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC)

Driving California's Energy Future: California Resources Corporation Releases 2025 Sustainability Update
globenewswire.com
Driving California's Energy Future: California Resources Corporation Releases 2025 Sustainability Up

LONG BEACH, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) t

Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
gurufocus.com
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lan

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the publication of primary analysis results

CRC Down 14.1% in 3 Months: Can Cost Gains Turn It Around?
zacks.com
CRC Down 14.1% in 3 Months: Can Cost Gains Turn It Around?

California Resources is cutting costs and improving drilling efficiency, but weaker estimates and ma

Is CRC Stock Worth Buying Despite Its Premium Valuation?
zacks.com
Is CRC Stock Worth Buying Despite Its Premium Valuation?

California Resources Corporation is cutting costs and improving well productivity, but a rich valuat

Can CRC's $63M Crimson Deal Ease California Constraints?
zacks.com
Can CRC's $63M Crimson Deal Ease California Constraints?

California Resources Corporation is adding pipelines, storage and market access after Q2 bottlenecks

benzinga.com
Barclays Maintains Overweight on California Resources, Lowers Price Target to $74

Barclays analyst Betty Jiang maintains California Resources (NYSE:CRC) with a Overweight and lowe

CRC Q2 Earnings Miss on Takeaway Constraints, Revenues Beat
zacks.com
CRC Q2 Earnings Miss on Takeaway Constraints, Revenues Beat

CRC's revenues surge 50.4% as Berry synergies, drilling gains and midstream expansion support growth

California Resources Corporation $CRC Shares Purchased by Bank of America Corp DE
defenseworld.net
California Resources Corporation $CRC Shares Purchased by Bank of America Corp DE

Bank of America Corp DE lifted its holdings in shares of California Resources Corporation (NYSE: CRC

benzinga.com
UBS Maintains Buy on California Resources, Lowers Price Target to $67

UBS analyst Josh Silverstein maintains California Resources (NYSE:CRC) with a Buy and lowers the

benzinga.com
Barclays Maintains Overweight on California Resources, Lowers Price Target to $77

Barclays analyst Betty Jiang maintains California Resources (NYSE:CRC) with a Overweight and lowe

benzinga.com
California Resources Q2 Adj. EPS $0.99 Misses $1.43 Estimate, Sales $1.297B Beat $976.559M Estimate

California Resources (NYSE:CRC) reported quarterly earnings of $0.99 per share which missed the anal

benzinga.com
Stephens & Co. Maintains Overweight on California Resources, Lowers Price Target to $85

Stephens & Co. analyst Mike Scialla maintains California Resources (NYSE:CRC) with a Overweig

benzinga.com
UBS Maintains Buy on California Resources, Lowers Price Target to $70

UBS analyst Josh Silverstein maintains California Resources (NYSE:CRC) with a Buy and lowers the

benzinga.com
Mizuho Maintains Outperform on California Resources, Raises Price Target to $87

Mizuho analyst Nitin Kumar maintains California Resources (NYSE:CRC) with a Outperform and raises

benzinga.com
California Resources Launches State's First Carbon Storage Project Capable of Holding 1.46M Tons of

California Resources Corporation (NYSE:CRC) has achieved the first landmark carbon dioxide (CO2) inj

benzinga.com
Citigroup Upgrades California Resources to Buy, Raises Price Target to $78

Citigroup analyst Scott Gruber upgrades California Resources (NYSE:CRC) from Neutral to Buy and r

benzinga.com
UBS Maintains Buy on California Resources, Lowers Price Target to $78

UBS analyst Josh Silverstein maintains California Resources (NYSE:CRC) with a Buy and lowers the

Full Transcript: California Resources Q1 2026 Earnings Call
benzinga.com
Full Transcript: California Resources Q1 2026 Earnings Call

benzinga.com
California Resources Q1 Adj. EPS $0.88 Beats $0.85 Estimate, Sales $119.000M Miss $936.631M Estimate

California Resources (NYSE:CRC) reported quarterly earnings of $0.88 per share which beat the analys

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

Earnings Scheduled For March 2, 2026
benzinga.com
Earnings Scheduled For March 2, 2026

This Coca-Cola Femsa Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday
benzinga.com
This Coca-Cola Femsa Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday

This Cloudflare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
benzinga.com
This Cloudflare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Earnings Scheduled For August 5, 2025

This Otis Worldwide Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
benzinga.com
This Otis Worldwide Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

benzinga.com
Earnings Scheduled For May 6, 2025

California Resources Faces Permit Challenges And Oversupply Risks—Analyst Sees Growth, But Stay Cautious
benzinga.com
California Resources Faces Permit Challenges And Oversupply Risks—Analyst Sees Growth, But Stay Caut

JP Morgan maintains Neutral rating on California Resources Corp. with $63 price target. Company face

US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff Talks: 'March, April, May Tend To Be Solid Months In Post-Election Years,' Says Expert
benzinga.com
US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff Talks: 'March, April, May Tend T

US. stock futures rose on Monday following Friday's advances. Futures of all fourth benchmark in

benzinga.com
Earnings Scheduled For March 3, 2025

California Resources, Okta And 3 Stocks To Watch Heading Into Monday
benzinga.com
California Resources, Okta And 3 Stocks To Watch Heading Into Monday

benzinga.com
Earnings Scheduled For February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

benzinga.com
Earnings Scheduled For November 1, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2023